Luke J. Laffin

Appropriateness of Cardiovascular Disease Prevention Recommendations Obtained From a Popular Online Chat-Based Artificial Intelligence Model

Ashish Sarraju, Dennis Bruemmer, Erik H. Van Iterson et al. · JAMA · 2023 · 455 citations · Full text

Artificial Intelligence, Clinical Innovation, Biomedical Artificial Intelligence +12

Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction

Gillian Murtagh, Luke J. Laffin, John F. Beshai et al. · Circulation Cardiovascular Imaging · 2016 · 213 citations · Full text

Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension

Luke J. Laffin, David Rodman, James M. Luther et al. · JAMA · 2023 · 159 citations · Full text

Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients

Steven E. Nissen, Venu Menon, Stephen J. Nicholls et al. · JAMA · 2023 · 119 citations · Full text

Amylose resistant starch (HAM‐RS2) supplementation increases the proportion of <i>Faecalibacterium</i> bacteria in end‐stage renal disease patients: Microbial analysis from a randomized placebo‐controlled trial

Michael Laffin, Hamid Tayebi Khosroshahi, Heekuk Park et al. · Hemodialysis International · 2019 · 88 citations